[Antitumor activity of prospidin].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D002284:Carcinoma, Brown-Pearce / Q000188:drug therapy; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D012516:Osteosarcoma / Q000188:drug therapy; D010879:Piperazines / Q000627:therapeutic use* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy; D012513:Sarcoma, Experimental / Q000188:drug therapy
D000970:Antineoplastic Agents; D010879:Piperazines
O protivoopukholevoĭ aktivnosti prospidina.